Rankings
▼
Calendar
HOTH Q3 2018 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOTH
Hoth Therapeutics, Inc.
$15M
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$620,233
Net Income
-$620,233
EPS (Diluted)
$-1.65
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$697,627
Free Cash Flow
-$697,627
Stock-Based Comp.
$5,590
Balance Sheet
Total Assets
$760,029
Total Liabilities
$25,701
Stockholders' Equity
$734,328
Cash & Equivalents
$737,683
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$620,233
-$214,552
-189.1%
Net Income
-$620,233
-$358,552
-73.0%
← FY 2018
All Quarters
Q4 2018 →